Literature DB >> 24998365

A modified method for heterotopic mouse heart transplantion.

Chuanmin Wang1, Zane Wang1, Richard Allen1, G Alex Bishop2, Alexandra F Sharland1.   

Abstract

Mice are often used as heart transplant donors and recipients in studies of transplant immunology due to the wide range of transgenic mice and reagents available. A difficulty is presented due to the small size of the animal and the considerable technical challenges of the microsurgery involved in heart transplantation. In particular, a high rate of technical failure early after transplantation may result from recipient death and post-operative complications such as hind limb paralysis or a non-beating heart. Here, the complete technique for heterotopic mouse heart transplantation is demonstrated, involving harvesting the donor heart and its subsequent implantation into a recipient mouse. The donor heart is harvested immediately following in situ perfusion with cold heparinized saline and transection of the ascending aorta and pulmonary artery. The recipient operation involves preparation of the abdominal aorta and inferior vena cava (IVC), followed by end-to-side anastomosis of the donor aorta with the recipient aorta using a single running 10-0 microsuture and a similar anastomosis of the donor pulmonary artery with the recipient IVC. Following the operation the animal is injected with 0.6 ml normal saline subcutaneously and allowed to recover on a 37 ° C heating pad. The results from 227 mouse heart transplants are summarized with a success rate at 48 hr of 86.8%. Of the 13.2% failures within 48 hr, 5 (2.2%) experienced hind limb paralysis, 10 (4.4%) had a non-beating heart due to graft ischemic injury and/or thrombosis, while 15 (6.6%) died within 48 hr.

Entities:  

Mesh:

Year:  2014        PMID: 24998365      PMCID: PMC4204913          DOI: 10.3791/51423

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection.

Authors:  R J Corry; H J Winn; P S Russell
Journal:  Transplantation       Date:  1973-10       Impact factor: 4.939

2.  Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments.

Authors:  Chuanmin Wang; Shaun Cordoba; Min Hu; Patrick Bertolino; David G Bowen; Alexandra F Sharland; Richard D M Allen; Stephen I Alexander; Geoffrey W McCaughan; G Alex Bishop
Journal:  Transpl Immunol       Date:  2011-01-01       Impact factor: 1.708

3.  Electrocardiographic monitoring of cardiac transplants in mice.

Authors:  P L Mottram; J A Smith; A Mason; A Mirisklavos; L J Dumble; G J Clunie
Journal:  Cardiovasc Res       Date:  1988-05       Impact factor: 10.787

4.  Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.

Authors:  S Qian; F Fu; Y Li; L Lu; A S Rao; T E Starzl; A W Thomson; J J Fung
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

5.  Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness.

Authors:  D Saitovitch; A Bushell; D W Mabbs; P J Morris; K J Wood
Journal:  Transplantation       Date:  1996-06-15       Impact factor: 4.939

6.  Interleukin-10 but not transforming growth factor-beta is essential for generation and suppressor function of regulatory cells induced by intratracheal delivery of alloantigen.

Authors:  Osamu Aramaki; Fumihiko Inoue; Tadatoshi Takayama; Motohide Shimazu; Masaki Kitajima; Yoshifumi Ikeda; Ko Okumura; Hideo Yagita; Nozomu Shirasugi; Masanori Niimi
Journal:  Transplantation       Date:  2005-03-15       Impact factor: 4.939

7.  Heterotopic heart transplantation in mice.

Authors:  Fengchun Liu; Sang Mo Kang
Journal:  J Vis Exp       Date:  2007-07-19       Impact factor: 1.355

8.  Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.

Authors:  Lionel F Poulin; Mélisande Richard; Alain Le Moine; Robert Kiss; Andrew N McKenzie; Michel Goldman; Jean-Christophe Renauld; Jacques Van Snick; Michel Y Braun
Journal:  Transplantation       Date:  2003-08-15       Impact factor: 4.939

9.  Expression of granzyme A and perforin in mouse heart transplants immunosuppressed with donor-specific transfusion and anti-CD4 monoclonal antibody.

Authors:  R H Chen; A Bushell; S V Fuggle; K J Wood; P J Morris
Journal:  Transplantation       Date:  1996-02-27       Impact factor: 4.939

10.  Regulation of allograft survival by inhibitory FcγRIIb signaling.

Authors:  Chris J Callaghan; Thet Su Win; Reza Motallebzadeh; Thomas M Conlon; Manu Chhabra; Inês Harper; Siva Sivaganesh; Eleanor M Bolton; J Andrew Bradley; Rebecca J Brownlie; Kenneth G C Smith; Gavin J Pettigrew
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

View more
  3 in total

1.  Linked sensitization by memory CD4+ T cells prevents costimulation blockade-induced transplantation tolerance.

Authors:  Michael S Andrade; James S Young; Jared M Pollard; Dengping Yin; Maria-Luisa Alegre; Anita S Chong
Journal:  JCI Insight       Date:  2022-06-08

2.  The heterotopic heart transplantation in mice as a small animal model to study mechanical unloading - Establishment of the procedure, perioperative management and postoperative scoring.

Authors:  Sumi Westhofen; Marisa Jelinek; Leonie Dreher; Daniel Biermann; Jack Martin; Helga Vitzhum; Hermann Reichenspurner; Heimo Ehmke; Alexander Peter Schwoerer
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

3.  Effect of Inhibition of the JAK2/STAT3 Signaling Pathway on the Th17/IL-17 Axis in Acute Cellular Rejection After Heart Transplantation in Mice.

Authors:  Ming Zhang; Ming Xu; Kaijie Wang; Long Li; Jinping Zhao
Journal:  J Cardiovasc Pharmacol       Date:  2021-04-07       Impact factor: 3.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.